Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B

OBJECTIVE: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination. PATIENTS AND METHODS: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019, throug...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsini Campioli, Cristina, Esquer Garrigos, Zerelda, Assi, Mariam, Go, John Raymond, Razonable, Raymund R., Beam, Elena, Yao, Joseph, Cummins, Nathan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240146/
https://www.ncbi.nlm.nih.gov/pubmed/34195546
http://dx.doi.org/10.1016/j.mayocpiqo.2020.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240146/
https://www.ncbi.nlm.nih.gov/pubmed/34195546
http://dx.doi.org/10.1016/j.mayocpiqo.2020.10.010

Ejemplares similares